Phase I/II study of CAR T therapy in patients with B-cell non-Hodgkin lymphomas
Phase of Trial: Phase I/II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs CAR-T cell therapy-Mustang Bio (Primary)
- Indications B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 08 Nov 2017 According to a Fortress Biotech media release, this trial began recruiting patients in the fourth quarter of 2017.
- 08 Nov 2017 Status changed from planning to recruiting according to a Fortress Biotech media release.
- 20 Sep 2017 New trial record